Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Makino

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Anticancer Research|March 16, 2004
Immunohistochemical dihydropyrimidine dehydrogenase expression is a good prognostic indicator for patients with Dukes' C colorectal cancerKentaro Oi, Masato Makino, Mai Ozaki, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 12, 2009
Multicenter safety study of mFOLFOX6 for unresectable advanced/recurrent colorectal cancer in elderly patientsShinichi Sugimoto, Kuniyuki Katano, Akiyoshi Kanazawa, et al.
International Journal of Cancer|January 5, 2002
Expression of heavy subunit of gamma-glutamylcysteine synthetase (gamma-GCSh) in human colorectal carcinomaShigeru Tatebe, Hitoshi Unate, Frank A Sinicrope, et al.
Translational Lung Cancer Research|February 11, 2021
A prospective phase II study of multimodal prophylactic treatment for afatinib-induced adverse events in advanced non-small cell lung cancer (Niigata Lung Cancer Treatment Group 1401)Masaaki Okajima, Satoru Miura, Satoshi Watanabe, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 7, 2013
The efficacy of triplet antiemetic therapy with 0.75 mg of palonosetron for chemotherapy-induced nausea and vomiting in lung cancer patients receiving highly emetogenic chemotherapySatoru Miura, Satoshi Watanabe, Kazuhiro Sato, et al.
Oncology|February 15, 2018
A Phase II Study of Irinotecan for Patients with Previously Treated Small-Cell Lung CancerRie Kondo, Satoshi Watanabe, Satoshi Shoji, et al.
Thoracic Cancer|September 12, 2019
Efficacy of EGFR-TKIs with or without upfront brain radiotherapy for EGFR-mutant NSCLC patients with central nervous system metastasesYu Saida, Satoshi Watanabe, Tetsuya Abe, et al.
Translational Lung Cancer Research|August 12, 2022
Phase II study of nanoparticle albumin-bound paclitaxel monotherapy for relapsed non-small cell lung cancer with patient-reported outcomes (NLCTG1302)Satoshi Shoji, Satoru Miura, Satoshi Watanabe, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Anticancer Research|March 16, 2004
Immunohistochemical dihydropyrimidine dehydrogenase expression is a good prognostic indicator for patients with Dukes' C colorectal cancerKentaro Oi, Masato Makino, Mai Ozaki, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 12, 2009
Multicenter safety study of mFOLFOX6 for unresectable advanced/recurrent colorectal cancer in elderly patientsShinichi Sugimoto, Kuniyuki Katano, Akiyoshi Kanazawa, et al.
International Journal of Cancer|January 5, 2002
Expression of heavy subunit of gamma-glutamylcysteine synthetase (gamma-GCSh) in human colorectal carcinomaShigeru Tatebe, Hitoshi Unate, Frank A Sinicrope, et al.
Translational Lung Cancer Research|February 11, 2021
A prospective phase II study of multimodal prophylactic treatment for afatinib-induced adverse events in advanced non-small cell lung cancer (Niigata Lung Cancer Treatment Group 1401)Masaaki Okajima, Satoru Miura, Satoshi Watanabe, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 7, 2013
The efficacy of triplet antiemetic therapy with 0.75 mg of palonosetron for chemotherapy-induced nausea and vomiting in lung cancer patients receiving highly emetogenic chemotherapySatoru Miura, Satoshi Watanabe, Kazuhiro Sato, et al.
Oncology|February 15, 2018
A Phase II Study of Irinotecan for Patients with Previously Treated Small-Cell Lung CancerRie Kondo, Satoshi Watanabe, Satoshi Shoji, et al.
Thoracic Cancer|September 12, 2019
Efficacy of EGFR-TKIs with or without upfront brain radiotherapy for EGFR-mutant NSCLC patients with central nervous system metastasesYu Saida, Satoshi Watanabe, Tetsuya Abe, et al.
Translational Lung Cancer Research|August 12, 2022
Phase II study of nanoparticle albumin-bound paclitaxel monotherapy for relapsed non-small cell lung cancer with patient-reported outcomes (NLCTG1302)Satoshi Shoji, Satoru Miura, Satoshi Watanabe, et al.
Pageof 2